Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Dermatology,Molecular Biology,Biochemistry
Reference23 articles.
1. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial;Arits;Lancet Oncol,2013
2. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma;Arits;Br J Dermatol,2014
3. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial;Basset-Seguin;Eur J Dermatol,2008
4. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial;Bath-Hextall;Lancet Oncol,2014
5. How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma;Com-Nougue;Stat Med,1993
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021;The Journal of Dermatology;2024-01-24
2. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches;Molecular Cancer;2023-10-06
3. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023;European Journal of Cancer;2023-10
4. Tirbanibulin ointment to manage recurrence of superficial basal cell carcinoma of the face: case report;Clinical and Experimental Dermatology;2023-09-27
5. Aktuelles Management des Basalzellkarzinoms;DMW - Deutsche Medizinische Wochenschrift;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3